Literature DB >> 7825564

Quantitative comparison of FMR1 gene expression in normal and premutation alleles.

Y Feng1, L Lakkis, D Devys, S T Warren.   

Abstract

We report studies on FMR1 gene expression in cells derived from male premutation carriers. Transcription of FMR1 genes with CGG-repeat lengths within the premutation range was demonstrated to be normal. Repeat lengths are faithfully transcribed into FMR1 mRNAs, which have steady-state levels, as measured by RNase protection, similar to those of normal cells. Premutation transcripts also are shown to have normal turnover, with the FMR1 mRNA half-life estimated to be 12 h. Measurement of FMR1 protein was also found to be in similar abundance in normal and premutation cell lines. These data support the nonpenetrant status of premutation carriers of fragile X syndrome and suggest that the occasional case reports to the contrary may reflect either other causes, including low-level mosaicism for larger, methylated FMR1 alleles, or simply coincidence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825564      PMCID: PMC1801331     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  50 in total

1.  Shadow bands seen when typing polymorphic dinucleotide repeats: some causes and cures.

Authors:  M Litt; X Hauge; V Sharma
Journal:  Biotechniques       Date:  1993-08       Impact factor: 1.993

2.  The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.

Authors:  H Siomi; M C Siomi; R L Nussbaum; G Dreyfuss
Journal:  Cell       Date:  1993-07-30       Impact factor: 41.582

3.  Fine structure of the human FMR1 gene.

Authors:  E E Eichler; S Richards; R A Gibbs; D L Nelson
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

4.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

5.  Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.

Authors:  A McConkie-Rosell; A M Lachiewicz; G A Spiridigliozzi; J Tarleton; S Schoenwald; M C Phelan; P Goonewardena; X Ding; W T Brown
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

6.  Genotype-phenotype relationships in fragile X syndrome: a family study.

Authors:  D Z Loesch; R Huggins; D A Hay; A K Gedeon; J C Mulley; G R Sutherland
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

7.  A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome.

Authors:  C Hull; R J Hagerman
Journal:  Am J Dis Child       Date:  1993-11

8.  Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat.

Authors:  C T Ashley; J S Sutcliffe; C B Kunst; H A Leiner; E E Eichler; D L Nelson; S T Warren
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

9.  Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.

Authors:  W T Brown; G E Houck; A Jeziorowska; F N Levinson; X Ding; C Dobkin; N Zhong; J Henderson; S S Brooks; E C Jenkins
Journal:  JAMA       Date:  1993-10-06       Impact factor: 56.272

10.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome.

Authors:  C Verheij; C E Bakker; E de Graaff; J Keulemans; R Willemsen; A J Verkerk; H Galjaard; A J Reuser; A T Hoogeveen; B A Oostra
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

View more
  19 in total

1.  Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

Authors:  F Tassone; R J Hagerman; A K Taylor; L W Gane; T E Godfrey; P J Hagerman
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes.

Authors:  Y Feng; C A Gutekunst; D E Eberhart; H Yi; S T Warren; S M Hersch
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

3.  Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.

Authors:  Gloria E Hoffman; Wei Wei Le; Ali Entezam; Noriyuki Otsuka; Zhi-Bin Tong; Lawrence Nelson; Jodi A Flaws; John H McDonald; Sanjeeda Jafar; Karen Usdin
Journal:  J Histochem Cytochem       Date:  2012-04-02       Impact factor: 2.479

4.  Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.

Authors:  B Genç; H Müller-Hartmann; M Zeschnigk; H Deissler; B Schmitz; F Majewski; A von Gontard; W Doerfler
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

5.  Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data.

Authors:  D J Allingham-Hawkins; R Babul-Hirji; D Chitayat; J J Holden; K T Yang; C Lee; R Hudson; H Gorwill; S L Nolin; A Glicksman; E C Jenkins; W T Brown; P N Howard-Peebles; C Becchi; E Cummings; L Fallon; S Seitz; S H Black; A M Vianna-Morgante; S S Costa; P A Otto; R C Mingroni-Netto; A Murray; J Webb; F Vieri
Journal:  Am J Med Genet       Date:  1999-04-02

6.  The fragile X mental retardation protein inhibits translation via interacting with mRNA.

Authors:  Z Li; Y Zhang; L Ku; K D Wilkinson; S T Warren; Y Feng
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

7.  Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.

Authors:  R D Hundscheid; E A Sistermans; C M Thomas; D D Braat; H Straatman; L A Kiemeney; B A Oostra; A P Smits
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

8.  Reproductive and menstrual history of females with fragile X expansions.

Authors:  A Murray; S Ennis; F MacSwiney; J Webb; N E Morton
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

9.  Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population.

Authors:  D C Crawford; K L Meadows; J L Newman; L F Taft; D L Pettay; L B Gold; S J Hersey; E F Hinkle; M L Stanfield; P Holmgreen; M Yeargin-Allsopp; C Boyle; S L Sherman
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Authors:  Dilek Colak; Nikica Zaninovic; Michael S Cohen; Zev Rosenwaks; Wang-Yong Yang; Jeannine Gerhardt; Matthew D Disney; Samie R Jaffrey
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.